[Chronic myelogenous leukemia complicated by drug-induced agranulocytosis].
Takafumi Nakao, Noriko Yoshida, Takahiko Nakane, Yoshiki Terada, Hirohisa Nakamae, Ki-Ryang Koh, Takahisa Yamane, Masayuki Hino
Index: Rinsho. Ketsueki. 52(5) , 278-81, (2011)
Full Text: HTML
Abstract
We describe a patient with chronic myelogenous leukemia (CML) who developed drug-induced agranulocytosis. A 75-year-old female was diagnosed with CML in December 2001. She had been receiving imatinib therapy for more than five years. In August 2007, she was hospitalized due to a severe neutropenia 10 days after colonoscopy. She was diagnosed as having agranulocytosis induced by colonoscopy premedication including scopolamine butylbromide and flumazenil. Severe neutropenia was resolved by G-CSF treatment without CML progression. Agranulocytosis in patients with CML is rare, but potentially lethal. Here, we report the clinical course in this patient.
Related Compounds
Related Articles:
2007-05-01
[Nat. Chem. Biol. 3(5) , 268-273, (2007)]
2015-01-01
[J. Gastroenterol. Hepatol. 30(1) , 86-91, (2014)]
2014-10-01
[AJR Am. J. Roentgenol. 203(4) , W400-7, (2014)]
2007-01-01
[Drugs 67(9) , 1343-57, (2007)]
2015-01-01
[AJR Am. J. Roentgenol. 204(1) , 76-82, (2015)]